StonvexLoading…
StonvexStonvexStonvexCore line items from EMPD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $974.98K | $3.98M | $3.26M | $4.55M |
Operating Income | $-153.48M | $-25.66M | $-29.79M | $-32.06M |
Net Income | $-150.05M | $-45.51M | $-45.07M | $-34.24M |
EPS (Diluted) | $-8.12 | $-1175.22 | $-187796.71 | $-325.20 |
Total Assets | $372.44M | $6.23M | $22.13M | $22.73M |
Total Liabilities | $103.22M | $6.19M | $41.76M | $22.09M |
Cash & Equivalents | $8.96M | $2.19M | $8.19M | $11.54M |
Free Cash Flow OCF − CapEx | $-18.05M | $-16.35M | $-30.52M | $-34.45M |
Shares Outstanding | 33.80M | 78.86K | 1.29K | 108.56K |